Global RSV Vaccine Market Size, Analysis, Insights, Forecast
The Global RSV Vaccine Market Size was Worth Around USD 1.47 Billion in 2024 and is Predicted to Grow to around USD 2.55 Billion by 2035 with a Compound Annual Growth Rate (CAGR) of 5.14% from 2025 to 2035. The Market Size is Growing due to government programs and healthcare organizations' efforts to promote immunization and increase public knowledge of the health hazards associated with RSV, which opens doors for vaccine developers and producers.